Ana Carla Oliveira

ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

Pier Luigi Zinzani, Christopher R. Flowers, Fontanet Bijou et al. · Journal of Clinical Oncology · 2023 · 98 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +11

Effects of intradialytic resistance training on physical activity in daily life, muscle strength, physical capacity and quality of life in hemodialysis patients: a randomized clinical trial

Felipe Martins do Valle, Bruno Valle Pinheiro, Ariane Aparecida Almeida Barros et al. · Disability and Rehabilitation · 2019 · 59 citations

Medicine, Nephrology, Rehabilitation Medicine +17

Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)

Pau Abrisqueta, Julio Delgado, Miguel Alcoceba et al. · British Journal of Haematology · 2020 · 57 citations · Full text

Medicine, Hematology, Oncology +17

Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results

Julio Delgado, Blanca Espinet, Ana Carla Oliveira et al. · British Journal of Haematology · 2012 · 46 citations · Full text

Medicine, Oncology, Pathology +13

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Pau Abrisqueta, Javier Loscertales, María José Terol et al. · Clinical Lymphoma Myeloma & Leukemia · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +14